20553

Injection(s); single or multiple trigger point(s), 3 or more muscle(s)

Current Procedural Terminology (CPT) code 20553 represents a minimally invasive pain management procedure involving the injection of single or multiple trigger points across three or more muscles. A trigger point is a hyperirritable spot within a taut band of skeletal muscle or its fascia, which often causes severe localized pain, restricted range of motion, and referred pain patterns. This procedure is commonly utilized in the treatment of myofascial pain syndrome, chronic muscle spasms, tension-type headaches, and other conditions characterized by persistent muscular discomfort that has not responded adequately to conservative therapies such as physical therapy, oral analgesics, or rest. During the procedure, the provider first performs a thorough physical examination to identify the exact locations of the trigger points through careful palpation, often eliciting a local twitch response or a recognizable pain pattern for the patient. Once identified, the overlying skin is cleansed with an antiseptic solution to maintain a sterile environment. A small-gauge needle is then advanced into the taut band of the muscle. The clinician typically aspirates to confirm that the needle tip is not within a blood vessel. Following this, a precisely measured volume of an injectable agent usually a combination of a local anesthetic, such as lidocaine or bupivacaine, and a corticosteroid to reduce inflammation is administered directly into the trigger point. The localized administration of the anesthetic provides immediate pain relief by interrupting the pain signaling pathways, while the corticosteroid works over the ensuing days to decrease local inflammation and prevent the recurrence of the spasm. The mechanical disruption of the muscle fibers by the needle itself also contributes to the relaxation of the taut band. For code 20553, this exact sequence is repeated across a minimum of three distinct muscles during the same patient encounter. It is imperative that the clinical documentation explicitly names each individual muscle treated to support the use of this specific code, as opposed to code 20552, which is reserved for injections involving only one or two muscles. Following the injections, the needle sites are compressed to achieve hemostasis, and a sterile dressing is applied. Patients are generally advised to perform gentle stretching exercises to maximize the therapeutic benefits of the injections and to facilitate the restoration of normal muscle mechanics.

Clinical Indications

  • Myofascial pain syndrome with identifiable taut muscle bands.
  • Chronic, refractory muscle spasms in the cervical, thoracic, or lumbar regions.
  • Tension-type headaches associated with pericranial or cervical muscle trigger points.
  • Fibromyalgia with specific localized hyperirritable nodules requiring targeted intervention.
  • Trapezius myalgia or levator scapulae syndrome causing severe neck and shoulder pain.

Procedure Steps

  1. Palpate the patient symptomatic regions to identify taut bands and hyperirritable nodules confirming the presence of trigger points.
  2. Cleanse the overlying skin with an appropriate antiseptic solution such as chlorhexidine or povidone-iodine.
  3. Insert a needle attached to a syringe containing the therapeutic agent (local anesthetic and/or corticosteroid) into the identified trigger point of the first muscle.
  4. Aspirate the syringe to verify that the needle is not inadvertently positioned within a blood vessel.
  5. Inject the therapeutic agent directly into the trigger point while monitoring patient response.
  6. Withdraw the needle and apply immediate pressure to the injection site to prevent bleeding and hematoma formation.
  7. Repeat steps three through six for trigger points located in the second distinct muscle.
  8. Repeat steps three through six for trigger points located in the third distinct muscle and any additional muscles as clinically indicated.
  9. Apply a sterile bandage to the injection sites and instruct the patient on post-procedure care including stretching and physical therapy.

Coding Guidelines

  • CPT code 20553 is reported only once per session regardless of the total number of trigger points or muscles injected if the total number of muscles is three or more.
  • Do not report 20553 in conjunction with 20552 (one or two muscles) during the same session.
  • Documentation must specifically name the individual muscles injected (e.g. right trapezius, left levator scapulae, right rhomboid) to justify the selection of 20553.
  • If imaging guidance such as ultrasound or fluoroscopy is used, it may be reported separately (e.g., 76942 or 77002) provided that the guidance is medically necessary and supported by payer-specific policies.
  • This code is for the injection of a therapeutic substance; dry needling without the injection of a substance should be reported using codes 20560 or 20561.

Associated ICD-10 Codes